Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
+$188M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$136M |
| 3 |
Danaher
DHR
|
+$133M |
| 4 |
Procter & Gamble
PG
|
+$112M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$101M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.29B |
| 2 |
Microsoft
MSFT
|
+$365M |
| 3 |
Alibaba
BABA
|
+$328M |
| 4 |
Ameren
AEE
|
+$220M |
| 5 |
American Electric Power
AEP
|
+$206M |
Sector Composition
| 1 | Healthcare | 20.2% |
| 2 | Technology | 12.94% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Intellicheck
IDN
$107M
| $192K | ﹤0.01% |
+56,741
| New | +$192K |
|
2702
ClearPoint Neuro
CLPT
$303M
| $191K | ﹤0.01% |
53,361
-18,112
| -25% | -$64.8K |
|
2703
Investar Holding Corp
ISTR
$221M
| $191K | ﹤0.01% |
14,987
-8,043
| -35% | -$103K |
|
|
ONCT
2704
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $191K | ﹤0.01% |
3,264
-144
| -4% | -$8.43K |
|
2705
Corbus Pharmaceuticals
CRBP
$126M
| $190K | ﹤0.01% |
+1,207
| New | +$190K |
|
2706
Boot Barn
BOOT
$5.49B
| $189K | ﹤0.01% |
14,589
+7,475
| +105% | +$96.8K |
|
|
ATCX
2707
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $189K | ﹤0.01% |
21,989
-585,625
| -96% | -$5.03M |
|
|
PBBI
2708
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
| $189K | ﹤0.01% |
+12,675
| New | +$189K |
|
2709
Biomerica
BMRA
$8.45M
| $187K | ﹤0.01% |
+3,277
| New | +$187K |
|
2710
Constellium
CSTM
$2.13B
| $187K | ﹤0.01% |
35,939
-304,113
| -89% | -$1.58M |
|
|
DX
2711
Dynex Capital
DX
$1.6B
| $186K | ﹤0.01% |
17,771
-370,415
| -95% | -$3.88M |
|
2712
Ecopetrol
EC
$19.3B
| $185K | ﹤0.01% |
19,495
-538,964
| -97% | -$5.11M |
|
|
ACOR
2713
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $184K | ﹤0.01% |
1,641
+1,466
| +838% | +$164K |
|
|
OPGN
2714
DELISTED
OpGen, Inc
OPGN
| $183K | ﹤0.01% |
358
-173
| -33% | -$88.4K |
|
2715
Alpha Pro Tech
APT
$50.1M
| $182K | ﹤0.01% |
+15,072
| New | +$182K |
|
2716
Brixmor Property Group
BRX
$8.54B
| $182K | ﹤0.01% |
+19,181
| New | +$182K |
|
|
MN
2717
DELISTED
MANNING & NAPIER, INC.
MN
| $182K | ﹤0.01% |
145,396
-6,383
| -4% | -$7.99K |
|
2718
Unum
UNM
$12.8B
| $181K | ﹤0.01% |
12,055
-268,961
| -96% | -$4.04M |
|
|
SWI
2719
DELISTED
SolarWinds Corporation Common Stock
SWI
| $181K | ﹤0.01% |
10,926
-27,451
| -72% | -$455K |
|
2720
LCNB Corp
LCNB
$225M
| $180K | ﹤0.01% |
+14,281
| New | +$180K |
|
|
MESO
2721
Mesoblast
MESO
$2B
| $179K | ﹤0.01% |
+20,405
| New | +$179K |
|
|
UBX
2722
DELISTED
Unity Biotechnology
UBX
| $178K | ﹤0.01% |
3,077
-36,857
| -92% | -$2.13M |
|
|
VCNX
2723
DELISTED
Vaccinex, Inc. Common Stock
VCNX
| $178K | ﹤0.01% |
212
-57
| -21% | -$47.9K |
|
2724
Babcock & Wilcox
BW
$311M
| $177K | ﹤0.01% |
173,441
+162,209
| +1,444% | +$166K |
|
|
ARR
2725
Armour Residential REIT
ARR
$1.68B
| $173K | ﹤0.01% |
+3,930
| New | +$173K |
|